|
SOCS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.772100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.482870E-03 |
| Normal-vs-Stage2 |
3.70379999999892E-05 |
| Normal-vs-Stage3 |
3.422900E-03 |
| Normal-vs-Stage4 |
3.224300E-03 |
| Stage1-vs-Stage2 |
1.996080E-02 |
| Stage1-vs-Stage3 |
9.672800E-01 |
| Stage1-vs-Stage4 |
9.617200E-01 |
| Stage2-vs-Stage3 |
1.037790E-01 |
| Stage2-vs-Stage4 |
8.110000E-02 |
| Stage3-vs-Stage4 |
9.984000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.015800E-04 |
| Normal-vs-AfricanAmerican |
9.817300E-03 |
| Normal-vs-Asian |
1.563020E-03 |
| Caucasian-vs-AfricanAmerican |
9.611200E-01 |
| Caucasian-vs-Asian |
5.705000E-01 |
| AfricanAmerican-vs-Asian |
7.323800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.058150E-03 |
| Normal-vs-Female |
8.602000E-04 |
| Male-vs-Female |
9.009800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.258400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.362200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.049660E-04 |
| Normal-vs-Age(81-100Yrs) |
7.663200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.469800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.550300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.072000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.410600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.520200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.206000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.723700E-02 |
| Classical-VS-Follicular |
2.607600E-01 |
| Classical-VS-Other |
5.821700E-02 |
| Classical-VS-Normal |
2.624000E-03 |
| Tall-VS-Follicular |
5.850800E-01 |
| Tall-VS-Other |
5.935600E-01 |
| Tall-VS-Normal |
1.219500E-04 |
| Follicular-VS-Other |
3.268400E-01 |
| Follicular-VS-Normal |
5.565000E-04 |
| Other-VS-Normal |
3.395100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.018510E-04 |
| Normal-vs-N1 |
8.584200E-03 |
| N0-vs-N1 |
2.226400E-01 |
|
|
